Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||
net income | 384,162,000 | 269,855,000 | 236,597,000 | 282,092,000 | 372,519,000 | 254,007,000 | 173,557,000 | 242,066,000 | 171,790,000 | 367,807,000 | 146,775,000 |
adjustments to reconcile net income to net cash from operating activities: | |||||||||||
depreciation expense | 230,371,000 | 231,730,000 | 217,888,000 | 215,539,000 | 212,122,000 | 206,923,000 | 212,269,000 | 210,694,000 | 200,982,000 | 200,546,000 | 204,743,000 |
amortization of deferred financing costs and debt discount | 3,893,000 | 3,047,000 | 3,233,000 | 3,285,000 | 3,387,000 | 3,325,000 | 3,283,000 | 3,282,000 | 3,098,000 | 3,121,000 | 3,231,000 |
amortization of stock-based compensation | 7,149,000 | 8,457,000 | 5,662,000 | 5,132,000 | 6,747,000 | 7,624,000 | 5,870,000 | 5,293,000 | 6,734,000 | 7,194,000 | 7,921,000 |
equity in income of, and return on, unconsolidated investments and noncontrolling interests, net of eliminations | -5,742,000 | ||||||||||
casualty and impairment loss | 0 | ||||||||||
expensed transaction, development and other pursuit costs, net of recoveries | 1,392,000 | 2,493,000 | 4,744,000 | ||||||||
cash flow hedge gains reclassified to earnings | |||||||||||
gain on sale of real estate assets | -180,364,000 | -122,127,000 | -173,327,000 | -68,767,000 | 62,000 | -77,578,000 | -22,331,000 | -187,760,000 | -318,000 | ||
increase in prepaid expenses and other assets | 504,000 | -26,906,000 | -8,963,000 | 1,807,000 | -20,794,000 | ||||||
increase in accrued expenses, other liabilities, accrued interest payable and resident security deposits | 69,581,000 | -11,599,000 | 10,582,000 | ||||||||
net cash from operating activities | 476,959,000 | 377,812,000 | 415,903,000 | 328,813,000 | 486,169,000 | 379,991,000 | 412,905,000 | 346,187,000 | 471,263,000 | 346,461,000 | 396,118,000 |
cash flows from investing activities: | |||||||||||
development/redevelopment of real estate assets including land acquisitions and deferred development costs | -300,433,000 | -312,084,000 | -237,282,000 | -259,357,000 | -251,844,000 | -232,332,000 | -207,568,000 | -210,304,000 | -238,404,000 | -223,778,000 | -229,361,000 |
acquisition of real estate assets, including partnership interest | |||||||||||
capital expenditures - existing real estate assets | -74,770,000 | -60,669,000 | -48,370,000 | -56,917,000 | -51,931,000 | -47,010,000 | -37,490,000 | -56,668,000 | -47,898,000 | -42,465,000 | -31,281,000 |
capital expenditures - non-real estate assets | -634,000 | -1,619,000 | -256,000 | -124,000 | -2,018,000 | -1,336,000 | -1,200,000 | -5,846,000 | -5,010,000 | -4,905,000 | -3,201,000 |
increase in payables for construction | -3,714,000 | 4,691,000 | -2,649,000 | -3,255,000 | -536,000 | -8,055,000 | 6,797,000 | 3,983,000 | 12,176,000 | ||
proceeds from sale of real estate, net of selling costs | 571,189,000 | 164,407,000 | 63,651,000 | ||||||||
note receivable lending | -4,697,000 | -3,070,000 | -12,560,000 | -24,175,000 | -23,403,000 | -21,649,000 | -20,861,000 | -35,186,000 | -20,508,000 | -13,074,000 | -14,034,000 |
note receivable payments | 0 | -84,000 | 109,000 | 0 | 0 | 180,000 | 57,000 | 23,000 | 0 | ||
distributions from unconsolidated entities and investment sale proceeds | 4,000,000 | ||||||||||
unconsolidated investments | -29,328,000 | -4,158,000 | -2,395,000 | -4,808,000 | -4,431,000 | -2,851,000 | -2,085,000 | -5,216,000 | -4,715,000 | -3,328,000 | -5,602,000 |
net cash from investing activities | -101,867,000 | -395,345,000 | -427,865,000 | -314,275,000 | -218,786,000 | -197,985,000 | -265,818,000 | -346,091,000 | -284,987,000 | -30,538,000 | -267,339,000 |
cash flows from financing activities: | |||||||||||
issuance of common stock | 0 | 2,684,000 | 693,000 | 3,303,000 | 3,261,000 | 3,606,000 | 365,000 | 1,896,000 | -149,000 | 494,824,000 | 135,000 |
repurchase of common stock | 0 | 0 | -782,000 | -1,129,000 | |||||||
dividends paid | -250,233,000 | -248,968,000 | -243,678,000 | -241,778,000 | -241,603,000 | -241,528,000 | -237,005,000 | -234,171,000 | -234,163,000 | -230,858,000 | -223,465,000 |
net borrowings under unsecured credit facility and commercial paper | -430,019,000 | 440,058,000 | 224,942,000 | ||||||||
repayments of mortgage notes payable, including prepayment penalties | -1,062,000 | -8,259,000 | -1,171,000 | -662,000 | -1,150,000 | -7,181,000 | -800,000 | -1,300,000 | -38,299,000 | -6,502,000 | -899,000 |
issuance of unsecured notes | 497,488,000 | 0 | 1,000 | ||||||||
repayment of unsecured notes | 0 | -350,000,000 | -150,000,000 | 0 | -250,000,000 | ||||||
payment of deferred financing costs | -4,037,000 | -1,000 | -190,000 | -3,354,000 | -218,000 | -3,302,000 | 0 | 0 | -662,000 | ||
receipt for termination of forward interest rate swaps | 0 | 0 | |||||||||
payments related to tax withholding for share-based compensation | -99,000 | -191,000 | -16,353,000 | -281,000 | -218,000 | -93,000 | -16,291,000 | -110,000 | -20,000 | -199,000 | -10,310,000 |
noncontrolling interests, joint venture and preferred equity transactions | -12,864,000 | -560,000 | -440,000 | -360,000 | -7,279,000 | -548,000 | |||||
net cash from financing activities | -348,573,000 | 93,798,000 | -36,007,000 | -539,939,000 | -240,259,000 | 159,797,000 | -254,497,000 | -249,242,000 | -353,168,000 | 255,011,000 | -486,960,000 |
net increase in cash, cash equivalents and restricted cash | 26,519,000 | -525,401,000 | 27,124,000 | -249,146,000 | |||||||
cash, cash equivalents and restricted cash, beginning of period | 0 | 0 | 267,076,000 | 0 | 0 | 530,960,000 | |||||
cash, cash equivalents and restricted cash, end of period | 26,519,000 | 76,265,000 | 219,107,000 | 27,124,000 | 341,803,000 | 423,550,000 | |||||
cash paid during the period for interest, net of amount capitalized | 32,918,000 | 90,254,000 | 40,160,000 | 33,236,000 | 64,942,000 | 37,242,000 | 36,439,000 | 60,427,000 | 33,814,000 | ||
equity in loss (income) of, and return on, unconsolidated investments and noncontrolling interests, net of eliminations | 3,573,000 | 3,093,000 | 2,437,000 | 2,273,000 | |||||||
cash flow hedge (gains) losses reclassified to earnings | -570,000 | -273,000 | -274,000 | ||||||||
acquisition of real estate assets | -197,133,000 | -187,362,000 | -186,056,000 | -216,171,000 | -132,541,000 | ||||||
(gain) loss on sale of real estate assets | -56,660,000 | ||||||||||
decrease in payables for construction | -3,400,000 | ||||||||||
net decrease in cash, cash equivalents and restricted cash | -47,969,000 | -107,410,000 | |||||||||
loss on extinguishment of debt | 0 | ||||||||||
equity in (income) loss of, and return on, unconsolidated investments and noncontrolling interests, net of eliminations | 5,597,000 | -22,718,000 | -1,457,000 | ||||||||
proceeds from sale of real estate and for-sale condominiums, net of selling costs | 208,471,000 | 326,483,000 | 172,460,000 | 3,865,000 | 107,619,000 | 106,573,000 | 248,940,000 | 3,964,000 | |||
noncontrolling interests and joint venture transactions | |||||||||||
cash, cash equivalents and restricted cash, beginning of year | |||||||||||
cash, cash equivalents and restricted cash, end of year | |||||||||||
cash paid during the year for interest, net of amount capitalized | |||||||||||
impairment loss | 0 | 0 | 1,415,000 | ||||||||
abandonment of development pursuits | 1,573,000 | 1,417,000 | 4,245,000 | 10,267,000 | 18,959,000 | 1,261,000 | 2,992,000 | ||||
increase in accrued expenses, other liabilities and accrued interest payable | 106,934,000 | -17,221,000 | 21,553,000 | -60,004,000 | 62,238,000 | -21,124,000 | 30,909,000 | ||||
cash flow hedge losses reclassified to earnings | -69,000 | 146,000 | 298,000 | 354,000 | 354,000 | 354,000 | |||||
distributions from unconsolidated entities | 83,000 | 1,526,000 | |||||||||
decrease in prepaid expenses and other assets | -3,753,000 | ||||||||||
casualty loss | 449,000 | 1,766,000 | 0 | 2,407,000 | |||||||
unrealized gain on terminated cash flow hedges | |||||||||||
redemption of noncontrolling interest and units for cash by minority partners | 0 | ||||||||||
payments to noncontrolling interest | |||||||||||
distributions to downreit partnership unitholders | 0 | -13,000 | -12,000 | ||||||||
distributions to joint venture and profit-sharing partners | -106,000 | -104,000 | -98,000 | ||||||||
preferred interest obligation redemption and dividends | -420,000 | 0 | -520,000 | ||||||||
decrease in resident security deposits, prepaid expenses and other assets | -27,017,000 | -1,439,000 | |||||||||
net increase in cash, cash equivalents and cash in escrow | |||||||||||
cash, cash equivalents and cash in escrow, beginning of period | 0 | 734,245,000 | |||||||||
cash, cash equivalents and cash in escrow, end of period | 570,934,000 | 376,064,000 | |||||||||
acquisition of/payments to noncontrolling interest | |||||||||||
net decrease in cash, cash equivalents and cash in escrow | -358,181,000 | ||||||||||
amortization of deferred financing costs | |||||||||||
amortization of debt discount | |||||||||||
equity in loss (income) of, and return on, unconsolidated entities and noncontrolling interests, net of eliminations | |||||||||||
real estate casualty loss | |||||||||||
gain on sale of for-sale condominiums | |||||||||||
increase in resident security deposits, prepaid expenses and other assets | |||||||||||
proceeds from the sale of for-sale condominiums, net of selling costs | |||||||||||
investments in unconsolidated entities | |||||||||||
issuance of mortgage notes payable | |||||||||||
receipt (payment) for termination of forward interest rate swaps | |||||||||||
cash, cash equivalents and cash in escrow, beginning of year | |||||||||||
cash, cash equivalents and cash in escrow, end of year |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
